liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
A Randomized Phase II Study Comparing Imatinib and the Combination of Imatinib and Pegylated Interferon Alpha-2b in Newly Diagnosed Non-High Risk Chronic Myeloid Leukemia (CML) Patients in Complete Hematological Remission After Imatinib Induction Therapy. in BLOOD, vol 114, issue 22, pp 1269-1270
Uppsala University Hospital.
University of Oslo, Rikshospital.
Umeå University Hospital.
Turku University.
Show others and affiliations
2009 (English)In: BLOOD, American Society of Hematology , 2009, Vol. 114, no 22, 1269-1270 p.Conference paper (Refereed)
Abstract [en]


Place, publisher, year, edition, pages
American Society of Hematology , 2009. Vol. 114, no 22, 1269-1270 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-58392ISI: 000272725803835OAI: diva2:343280
Available from: 2010-08-13 Created: 2010-08-11 Last updated: 2010-08-13

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Malm, Claes
By organisation
Oncology Faculty of Health SciencesDepartment of Haematology UHL
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 35 hits
ReferencesLink to record
Permanent link

Direct link